| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.4M | +52.2% |
| Cost of Revenue | $18.7M | +82.0% |
| Gross Profit | $24.7M | +35.4% |
| R&D Expense | $31.6M | +52.4% |
| SG&A Expense | $40.5M | +223.3% |
| Operating Income | -$67.8M | -360.8% |
| Interest Expense | $11.4M | +68.6% |
| Pre-tax Income | -$37.6M | -217.1% |
| Income Tax | $497K |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.3M | +601.7% |
| Accounts Receivable | $10.2M | +171.9% |
| Current Assets | $131.6M | +8107.0% |
| Total Assets | $290.2M | +25.3% |
| Current Liabilities | $24.9M | +2328.6% |
| Long-term Debt | $51.1M | +91.9% |
| Total Liabilities | $100.0M | +1001.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.0M | -292.5% |
| Capital Expenditures | $15.4M | +49.5% |
| Investing Cash Flow | -$119.5M | -1047.2% |
| Financing Cash Flow | $270.5M | +1527.4% |
| Free Cash Flow | -$73.4M | -192.6% |
| +24.3% |
| Net Income | -$38.1M | -17.2% |
| EPS (Basic) | -$0.61 | +67.0% |
| EPS (Diluted) | -$0.61 | +67.0% |
| Stockholders' Equity |
| $190.2M |
| +3704.1% |